Citation:
Deborah Kim, Lee, Kyung Min , Freiman, Marc R. , Powell, W. Ryan , Klings, Elizabeth S. , Rinne, Seppo T. , Miller, Donald R. , Rose, Adam J. , and Wiener, Renda Soylemez . 2018. “Phosphodiesterase-5 Inhibitor Therapy For Pulmonary Hypertension In The United States. Actual Versus Recommended Use”. Annals Of The American Thoracic Society, 15, 6, Pp. 693–701. doi:10.1513/annalsats.201710-762oc.